Breast Biopsy Devices Market by Product, End-users, Modality, and Geography - Global Forecast & Analysis 2019-2023

乳房生検デバイスの世界市場予測・分析:生検針及びシステム、生検画像誘導システム

◆タイトル:Breast Biopsy Devices Market by Product, End-users, Modality, and Geography - Global Forecast & Analysis 2019-2023
◆商品コード:IRTNTR32121
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2019年9月
◆ページ数:175
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

Technavio社の本調査レポートでは、乳房生検デバイスの世界市場について調べ、乳房生検デバイスの市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、乳房生検デバイスの市場規模をセグメンテーション別(製品別(生検針及びシステム、生検画像誘導システム、その他)、モダリティ別、エンドユーザー別)と地域別(グローバル)に分けて算出しました。Technavio社は乳房生検デバイスの世界市場規模が2019-2023期間中に年平均10%成長すると予測しています。
・サマリー
・レポートの範囲
・乳房生検デバイスの市場状況
・乳房生検デバイスの市場規模
・乳房生検デバイスの市場予測
・乳房生検デバイスの世界環境:ファイブフォース分析
・市場セグメンテーション:製品別(生検針及びシステム、生検画像誘導システム、その他)
・市場セグメンテーション:モダリティ別
・市場セグメンテーション:エンドユーザー別
・乳房生検デバイスの顧客状況
・主要地域別市場規模:グローバル
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...

Global Breast Biopsy Devices Market: About this market
Technavio’s breast biopsy devices market analysis considers sales from biopsy needles and systems, biopsy image-guided systems, and other products. Our analysis report also considers finds the sales of breast biopsy devices in Asia, Europe, North America, and ROW. In 2018, the biopsy needles and systems segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the reduced technical complexities associated with biopsy needles and systems will play a significant role in the biopsy needles and systems segment to maintain its market position. Also, our global breast biopsy devices market report looks at factors such as the growing prevalence of breast cancer cases and an increasing number of products showcasing and approvals. However, high cost of breast biopsy, presence of alternative non-invasive procedures, and complications associated with breast biopsy and lack of trained professionals may hamper the growth of the breast biopsy devices industry over the forecast period.

Global Breast Biopsy Devices Market: Overview
Growing prevalence of breast cancer cases
Breast cancer is a deadly health condition and prevalent in women across the world. Even young women have a higher risk of developing breast cancer if they have a genetic propensity for ovarian and breast cancer or if there is a mutation in their BRCAI and BRCA2 gene. This is driving the need to create awareness and treat the patients after a proper analysis. Professionals are gathering a wide range of accumulative data and establishing facilities to encourage patients to undergo screening and diagnosis. This will boost the demand for breast biopsy procedures in various healthcare units. This growing prevalence of breast cancer cases will lead to the expansion of the global breast biopsy devices market at a CAGR of over 10% during the forecast period.

Paradigm shift toward the adoption of breast biopsy robot systems
There is an increase in the demand for technologically advanced breast biopsy devices comprising of robotic platforms, artificial intelligence, and surgical navigation systems. This is due to the growing demand need for minimally invasive procedures and accurate accurate and efficient surgical procedures. Vendors are focusing on improving the healthcare outcomes by developing technological solutions integrated with AI. This development is expected to have a positive impact on the overall market growth.
For the detailed list of factors that will drive the global breast biopsy devices market during the forecast period 2019-2023, click here.

Competitive Landscape
With the presence of several major players, the global breast biopsy devices market is fragmented. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading breast biopsy devices manufacturers, that include Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, and Siemens Healthineers AG.
Also, the breast biopsy devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming future growth opportunities.

【資料の目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• Biopsy needles and systems – Market size and forecast 2018-2023
• Biopsy image-guided systems – Market size and forecast 2018-2023
• Others – Market size and forecast 2018-2023
• Market opportunity by product
PART 07: MARKET SEGMENTATION BY MODALITY
• Stereotactic X-ray guided breast biopsy
• Ultrasound-guided breast biopsy
• MRI-guided breast biopsy
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY END-USER
• Hospitals
• ASCs
• Breast cancer specialty centers and clinics
• Others
PART 10: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
• PART 15: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendor
• Argon Medical Devices, Inc.
• Becton, Dickinson and Co.
• Carestream Health Inc.
• Danaher Corp.
• FUJIFILM Holdings Corp.
• General Electric Co.
• Hologic Inc.
• Planmed Oy
• Scion Medical Technologies LLC
• Siemens Healthineers AG
PART 16: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 17: EXPLORE TECHNAVIO


Exhibit 01: Product overview
Exhibit 02: Global medical devices market
Exhibit 03: Segments of global medical devices market
Exhibit 04: Market characteristics
Exhibit 05: Market segments
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2018
Exhibit 18: Product – Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Biopsy needles and systems – Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Biopsy needles and systems – Year-over-year growth 2019-2023 (%)
Exhibit 22: Biopsy image-guided systems – Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Biopsy image-guided systems – Year-over-year growth 2019-2023 (%)
Exhibit 24: Others – Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Others – Year-over-year growth 2019-2023 (%)
Exhibit 26: Market opportunity by product
Exhibit 27: Global breast biopsy devices market by modality (based on biopsy image-guided systems) in 2018
Exhibit 28: Customer landscape
Exhibit 29: Global breast biopsy devices market by end-user 2018
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 33: North America – Year-over-year growth 2019-2023 (%)
Exhibit 34: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Estimated cancer incidence in European countries 2018
Exhibit 36: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 37: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 39: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 40: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 41: Key leading countries
Exhibit 42: Reimbursement by Medicare for breast biopsy in the US
Exhibit 43: Market opportunity
Exhibit 44: Estimated incidence cases of cancer in European countries (2018)
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Business strategies and their market impact analysis
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: Argon Medical Devices Inc. – Vendor overview
Exhibit 53: Argon Medical Devices Inc. – Business segments
Exhibit 54: Argon Medical Devices Inc. – Organizational developments
Exhibit 55: Argon Medical Devices Inc. – Key offerings
Exhibit 56: Argon Medical Devices Inc. – Key customers
Exhibit 57: Becton, Dickinson and Co. – Vendor overview
Exhibit 58: Becton, Dickinson and Co. – Product segments
Exhibit 59: Becton, Dickinson and Co. – Organizational developments
Exhibit 60: Becton, Dickinson and Co. – Geographic focus
Exhibit 61: Becton, Dickinson and Co. – Segment focus
Exhibit 62: Becton, Dickinson and Co. – Key offerings
Exhibit 63: Becton, Dickinson and Co. – Key customers
Exhibit 64: Carestream Health Inc. – Vendor overview
Exhibit 65: Carestream Health Inc. – Business segments
Exhibit 66: Carestream Health Inc. – Organizational developments
Exhibit 67: Carestream Health Inc. – Key offerings
Exhibit 68: Carestream Health Inc. – Key customers
Exhibit 69: Danaher Corp. – Vendor overview
Exhibit 70: Danaher Corp. – Business segments
Exhibit 71: Danaher Corp. – Organizational developments
Exhibit 72: Danaher Corp. – Geographic focus
Exhibit 73: Danaher Corp. – Segment focus
Exhibit 74: Danaher Corp. – Key offerings
Exhibit 75: Danaher Corp. – Key customers
Exhibit 76: FUJIFILM Holdings Corp. – Vendor overview
Exhibit 77: FUJIFILM Holdings Corp. – Business segments
Exhibit 78: FUJIFILM Holdings Corp. – Organizational developments
Exhibit 79: FUJIFILM Holdings Corp. – Geographic focus
Exhibit 80: FUJIFILM Holdings Corp. – Segment focus
Exhibit 81: FUJIFILM Holdings Corp. – Key offerings
Exhibit 82: FUJIFILM Holdings Corp. – Key customers
Exhibit 83: General Electric Co. – Vendor overview
Exhibit 84: General Electric Co. – Business segments
Exhibit 85: General Electric Co. – Organizational developments
Exhibit 86: General Electric Co. – Geographic focus
Exhibit 87: General Electric Co. – Segment focus
Exhibit 88: General Electric Co. – Key offerings
Exhibit 89: General Electric Co. – Key customers
Exhibit 90: Hologic Inc. – Vendor overview
Exhibit 91: Hologic Inc. – Business segments
Exhibit 92: Hologic Inc. – Organizational developments
Exhibit 93: Hologic Inc. – Geographic focus
Exhibit 94: Hologic Inc. – Segment focus
Exhibit 95: Hologic Inc. – Key offerings
Exhibit 96: Hologic Inc. – Key customers
Exhibit 97: Planmed Oy – Vendor overview
Exhibit 98: Planmed Oy – Product segments
Exhibit 99: Planmed Oy – Organizational developments
Exhibit 100: Planmed Oy – Key offerings
Exhibit 101: Planmed Oy – Key customers
Exhibit 102: Scion Medical Technologies LLC – Vendor overview
Exhibit 103: Scion Medical Technologies LLC – Product segments
Exhibit 104: Scion Medical Technologies LLC – Key offerings
Exhibit 105: Scion Medical Technologies LLC – Key customers
Exhibit 106: Siemens Healthineers AG – Vendor overview
Exhibit 107: Siemens Healthineers AG – Business segments
Exhibit 108: Siemens Healthineers AG – Organizational developments
Exhibit 109: Siemens Healthineers AG – Geographic focus
Exhibit 110: Siemens Healthineers AG – Segment focus
Exhibit 111: Siemens Healthineers AG – Key offerings
Exhibit 112: Siemens Healthineers AG – Key customers
Exhibit 113: Validation techniques employed for market sizing
Exhibit 114: Definition of market positioning of vendors



【掲載企業】

Argon Medical Devices, Inc.
Becton, Dickinson and Co.
Carestream Health Inc.
Danaher Corp.
FUJIFILM Holdings Corp.
General Electric Co.
Hologic Inc.
Planmed Oy
Scion Medical Technologies LLC
Siemens Healthineers AG

★調査レポート[乳房生検デバイスの世界市場予測・分析:生検針及びシステム、生検画像誘導システム] (Breast Biopsy Devices Market by Product, End-users, Modality, and Geography - Global Forecast & Analysis 2019-2023 / IRTNTR32121)販売に関する免責事項
[乳房生検デバイスの世界市場予測・分析:生検針及びシステム、生検画像誘導システム] (Breast Biopsy Devices Market by Product, End-users, Modality, and Geography - Global Forecast & Analysis 2019-2023 / IRTNTR32121)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆